title: [Clinical outcomes research of Shenmai injection based on hospital information system].
abstract: OBJECTIVE
  To research the actual clinical applications of Shenmai injection based on the real world-HIS (hospital information system).
  
  
  METHODS
  The data of patients injected with Shenmai is analyzed. This information is collected from HIS in twenty hospitals of grade III-A. Many indexes are included such as age, sex, occupation, admission condition, hospitalization days, critical days, diagnosis of traditional and western medicine, dosage of drug, route of administration, drug combination and so on.
  
  
  RESULTS
  The age of patients between 46 and 65 is the most. The hospitalization day between 15 and 28 is the most. The Shenmai injection is more used for such diseases as coronary heart disease, hypertension, arrhythmia, cardiac insufficiency. About 97.55% of route of administration in medical order are consistent with specification. The main combination drugs of Shenmai injection are analyzed for adjuvant therapy of tumor, shock and coronary heart disease.
  
  
  CONCLUSIONS
  The Shenmai injection, as a traditional Chinese medicine injection, has the advantages of extensive indication and is used widely in clinical. The researching result based on HIS is objective and real. It can be referenced by researchers and clinician.
authors.affiliation: Institute of Basic Research in Clinical Medcine, China Academy of Chinese Medical Sciences, Beijing 100700, China. wanglianxin_tcm@126.com
authors.forename: Lian-Xin
authors.initials: LX
authors.lastname: Wang
authors.forename: Yan-Ming
authors.initials: YM
authors.lastname: Xie
authors.forename: Wei
authors.initials: W
authors.lastname: Yang
authors.forename: Hao
authors.initials: H
authors.lastname: Tang
authors.forename: Hu
authors.initials: H
authors.lastname: Yang
authors.forename: Yan
authors.initials: Y
authors.lastname: Zhuang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004338:Drug Combinations; D004358:Drug Therapy; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D041743:Herb-Drug Interactions; D006751:Hospital Information Systems; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D055815:Young Adult
chemical_list: D004338:Drug Combinations; D004365:Drugs, Chinese Herbal; C009252:fructus schizandrae, radix ginseng, radix ophiopogonis drug combination